BPRCX 714
BPRCX 714 is a CXCR4 (CXC chemokine receptor type 4) receptor antagonist. BPRCX 714 can be used for the study of hepatocellular carcinoma[1].
Product Specifications
CAS Number
[1892574-13-8]
UNSPSC
12352005
Target
CXCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Field of Research
Cancer
Smiles
O=C(O)CNCCC(N1CCC(NC2=NC(NCC3=CN(CCCNCCCNC4CCCCC4)N=N3)=NC(C)=C2)CC1)=O
Molecular Formula
C30H51N11O3
Molecular Weight
613.80
References & Citations
[1]Song JS, et al. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proc Natl Acad Sci U S A. 2021 Mar 30;118 (13) :e2015433118.|[2]Song JS, et al. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proc Natl Acad Sci U S A. 2021 Mar 30;118 (13) :e2015433118.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
